OPCH

SEC source: 0000899243-17-022669 · doc4a.xml · nonDerivative · entry 1

Coliseum Capital Management, LLC · CIK 0001409751 · Director · 10% owner

Shackelton Christopher S · CIK 0001430708 · Director · 10% owner

Coliseum Capital, LLC · CIK 0001409585 · Director · 10% owner

COLISEUM CAPITAL PARTNERS, L.P. · CIK 0001356974 · Director · 10% owner

Coliseum Capital Partners II, L.P. · CIK 0001567187 · Director · 10% owner

Gray Adam · CIK 0001454123 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 5,642,410

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of phantom stock is the economic equivalent of one share of the Issuer's common stock (the "Common Stock"). Each share of phantom stock is entitled to a cash payment equal to the fair market value of one share of the Common Stock as of the payment date based on the closing market price of the Common Stock on such date.

F6 · balance_after: These shares were omitted from the reporting person's original Form 4 filed with the Securities and Exchange Comission on August 17, 2017.

F4 · ownership.nature: The Common Stock is held directly by (a) CCP, an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser, (b) Coliseum Capital Partners II, L.P. ("CCP2" and, together with CCP, the "Funds"), an investment limited partnership of which CC is general partner and for which CCM serves as investment adviser, and (c) a separate account investment advisory client of CCM (the "Separate Account").

F5 · ownership.nature: Shackelton and Adam Gray ("Gray") are managers of and have an ownership interest in each of CCM and CC, and may be deemed to have an indirect pecuniary interest in the shares held by the Funds and the Separate Account due to CCM's right to receive performance-related fees from the Separate Account and CC's right to receive performance-related fees from the Funds. Each of Shackelton, Gray, CCP, CCP2, the Separate Account, CC and CCM disclaims beneficial ownership of these securities except to the extent of that person's pecuniary interest therein.

SEC source: 0001127602-17-022832 · form4.xml · nonDerivative · entry 1

Pate R Carter · CIK 0001641406 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 162,405

SEC source: 0000899243-17-011896 · doc4.xml · derivative · entry 1

Coliseum Capital Management, LLC · CIK 0001409751 · Director · 10% owner

Shackelton Christopher S · CIK 0001430708 · Director · 10% owner

Coliseum Capital, LLC · CIK 0001409585 · Director · 10% owner

COLISEUM CAPITAL PARTNERS, L.P. · CIK 0001356974 · Director · 10% owner

Coliseum Capital Partners II, L.P. · CIK 0001567187 · Director · 10% owner

Gray Adam · CIK 0001454123 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 49,669

Underlying: Common Stock · 49,669 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of the Issuer's common stock (the "Common Stock"). Each share of phantom stock is entitled to a cash payment equal to the fair market value of one share of the Common Stock as of the payment date based on the closing market price of the Common Stock on such date.

F2 · derivative.exercise_date: The fair market value of the shares of phantom stock will be equal to the closing price of the Issuer's Common Stock on the business day immediately preceding the 2018 annual meeting of the Issuer's stockholders.

F2 · derivative.expiration_date: The fair market value of the shares of phantom stock will be equal to the closing price of the Issuer's Common Stock on the business day immediately preceding the 2018 annual meeting of the Issuer's stockholders.

F3 · ownership.nature: The phantom stock was received by Christopher Shackelton ("Shackelton") in connection with his service as a member of the board of directors of the Issuer. Shackelton has agreed that all equity awards he receives for serving as a director of the Issuer shall be issued to Coliseum Capital Partners, L.P. ("CCP").

F4 · ownership.nature: The Common Stock is held directly by (a) CCP, an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser, (b) Coliseum Capital Partners II, L.P. ("CCP2" and, together with CCP, the "Funds"), an investment limited partnership of which CC is general partner and for which CCM serves as investment adviser, and (c) a separate account investment advisory client of CCM (the "Separate Account").

F5 · ownership.nature: Shackelton and Adam Gray ("Gray") are managers of and have an ownership interest in each of CCM and CC, and may be deemed to have an indirect pecuniary interest in the shares held by the Funds and the Separate Account due to CCM's right to receive performance-related fees from the Separate Account and CC's right to receive performance-related fees from the Funds. Each of Shackelton, Gray, CCP, CCP2, the Separate Account, CC and CCM disclaims beneficial ownership of these securities except to the extent of that person's pecuniary interest therein.

SEC source: 0001127602-17-016827 · form4.xml · nonDerivative · entry 1

GOLDING DAVID W · CIK 0001286630 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,169

F1 · shares: Vests and becomes non-forfeitable on the day before the Company's 2018 Annual Meeting.

SEC source: 0001127602-17-016829 · form4.xml · nonDerivative · entry 1

Bronfein Michael G · CIK 0001345949 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,669

F1 · shares: Vests and becomes non-forfeitable on the day before the Company's 2018 Annual Meeting.

SEC source: 0001127602-17-016825 · form4.xml · nonDerivative · entry 1

GOLDSTEIN MICHAEL · CIK 0001043027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,169

F1 · shares: Vests and becomes non-forfeitable on the day before the Company's 2018 Annual Meeting.

SEC source: 0001127602-17-016821 · form4.xml · nonDerivative · entry 1

Nguyen Tricia · CIK 0001596982 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,669

F1 · shares: Vests and becomes non-forfeitable on the day before the Company's 2018 Annual Meeting.

SEC source: 0001127602-17-016819 · form4.xml · nonDerivative · entry 1

Pate R Carter · CIK 0001641406 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,669

F1 · shares: Vests and becomes non-forfeitable on the day before the Company's 2018 Annual Meeting.

SEC source: 0001127602-17-015449 · form4.xml · derivative · entry 2

Deitsch Stephen · CIK 0001704288 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,902

Underlying: Common Stock, $.0001 Par Value · 66,902 shares

Expires 2019-12-31

F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels.

F3 · derivative.exercise_price: Depending on Company stock price at the end of the performance period, payout may be 0%, 50%, 100% or 150% of reported amount.

F3 · shares: Depending on Company stock price at the end of the performance period, payout may be 0%, 50%, 100% or 150% of reported amount.

F2 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels.

SEC source: 0001127602-17-015449 · form4.xml · derivative · entry 1

Deitsch Stephen · CIK 0001704288 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,909

Underlying: Common Stock, $.0001 Par Value · 215,909 shares

Expires 2027-04-24

F1 · derivative.exercise_date: Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.

SEC source: 0000899243-17-008732 · doc4.xml · derivative · entry 1

Coliseum Capital Management, LLC · CIK 0001409751 · Director · 10% owner

Shackelton Christopher S · CIK 0001430708 · Director · 10% owner

Coliseum Capital, LLC · CIK 0001409585 · Director · 10% owner

COLISEUM CAPITAL PARTNERS, L.P. · CIK 0001356974 · Director · 10% owner

Coliseum Capital Partners II, L.P. · CIK 0001567187 · Director · 10% owner

Gray Adam · CIK 0001454123 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2017-05-01

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of the Issuer's common stock (the "Common Stock"). Each share of phantom stock is entitled to a cash payment equal to the fair market value of one share of the Common Stock as of the payment date based on the closing market price of the Common Stock on such date.

F2 · derivative.exercise_date: The fair market value of the shares of phantom stock will be equal to the closing price of the Issuer's Common Stock on the business day immediately preceding the 2017 annual meeting of the Issuer's stockholders. The Issuer filed a preliminary proxy statement on March 24, 2017 establishing May 2, 2017 as the date of the Issuer's 2017 annual meeting of stockholders. Therefore, the fair market value of the shares of phantom stock will be equal to the closing price of the Issuer's Common Stock on May 1, 2017, or such later date if the annual meeting date is changed by the Issuer.

F2 · derivative.expiration_date: The fair market value of the shares of phantom stock will be equal to the closing price of the Issuer's Common Stock on the business day immediately preceding the 2017 annual meeting of the Issuer's stockholders. The Issuer filed a preliminary proxy statement on March 24, 2017 establishing May 2, 2017 as the date of the Issuer's 2017 annual meeting of stockholders. Therefore, the fair market value of the shares of phantom stock will be equal to the closing price of the Issuer's Common Stock on May 1, 2017, or such later date if the annual meeting date is changed by the Issuer.

F3 · ownership.nature: The phantom stock was received by Christopher Shackelton ("Shackelton") in connection with his service as a member of the board of directors of the Issuer. Shackelton has agreed that all equity awards he receives for serving as a director of the Issuer shall be issued to Coliseum Capital Partners, L.P. ("CCP").

F4 · ownership.nature: The Common Stock is held directly by (a) CCP, an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser, (b) Coliseum Capital Partners II, L.P. ("CCP2" and, together with CCP, the "Funds"), an investment limited partnership of which CC is general partner and for which CCM serves as investment adviser, and (c) a separate account investment advisory client of CCM (the "Separate Account").

F5 · ownership.nature: Shackelton and Adam Gray ("Gray") are managers of and have an ownership interest in each of CCM and CC, and may be deemed to have an indirect pecuniary interest in the shares held by the Funds and the Separate Account due to CCM's right to receive performance-related fees from the Separate Account and CC's right to receive performance-related fees from the Funds. Each of Shackelton, Gray, CCP, CCP2, the Separate Account, CC and CCM disclaims beneficial ownership of these securities except to the extent of that person's pecuniary interest therein.

SEC source: 0001127602-17-012143 · form4.xml · derivative · entry 2

Schott Alex · CIK 0001685340 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,760

Underlying: Common Stock, $.0001 Par Value · 38,760 shares

Expires 2027-03-15

F3 · derivative.exercise_date: Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.

SEC source: 0001127602-17-012143 · form4.xml · derivative · entry 1

Schott Alex · CIK 0001685340 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,837

Underlying: Common Stock, $.0001 Par Value · 12,500 shares

Expires 2019-12-31

F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels.

F2 · derivative.exercise_price: Depending on Company stock price at the end of the performance period, payout may be 0%, 50%, 100% or 150% of reported amount.

F2 · shares: Depending on Company stock price at the end of the performance period, payout may be 0%, 50%, 100% or 150% of reported amount.

F1 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels.

SEC source: 0001127602-17-012141 · form4.xml · derivative · entry 2

Kreger Jeffrey M · CIK 0001383865 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,760

Underlying: Common Stock, $.0001 Par Value · 38,760 shares

Expires 2027-03-15

F3 · derivative.exercise_date: Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.

SEC source: 0001127602-17-012141 · form4.xml · derivative · entry 1

Kreger Jeffrey M · CIK 0001383865 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,837

Underlying: Common Stock, $.0001 Par Value · 12,500 shares

Expires 2019-12-31

F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels.

F2 · derivative.exercise_price: Depending on Company's stock price, as measured by 20-day average stock price ending December 31, 2019, payout may be 0%, 50%, 100% or 150% of reported amount.

F2 · shares: Depending on Company's stock price, as measured by 20-day average stock price ending December 31, 2019, payout may be 0%, 50%, 100% or 150% of reported amount.

F1 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels.

SEC source: 0001127602-17-012139 · form4.xml · derivative · entry 2

Evans Dave · CIK 0001545303 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,380

Underlying: Common Stock, $.0001 Par Value · 19,380 shares

Expires 2027-03-15

F3 · derivative.exercise_date: Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.

SEC source: 0001127602-17-012139 · form4.xml · derivative · entry 1

Evans Dave · CIK 0001545303 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,919

Underlying: Common Stock, $.0001 Par Value · 6,250 shares

Expires 2019-12-31

F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels.

F2 · derivative.exercise_price: Depending on Company's stock price, as measured by 20-day average stock price ending December 31, 2019, payout may be 0%, 50%, 100% or 150% of reported amount.

F2 · shares: Depending on Company's stock price, as measured by 20-day average stock price ending December 31, 2019, payout may be 0%, 50%, 100% or 150% of reported amount.

F1 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels.

SEC source: 0001127602-17-012137 · form4.xml · derivative · entry 1

Jeffcoat C. Britt · CIK 0001643306 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,380

Underlying: Common Stock, $.0001 Par Value · 19,380 shares

Expires 2027-03-15

F1 · derivative.exercise_date: Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.

SEC source: 0001127602-17-012135 · form4.xml · derivative · entry 1

Kepler Jody · CIK 0001693167 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,760

Underlying: Common Stock, $.0001 Par Value · 38,760 shares

Expires 2027-03-15

F1 · derivative.exercise_date: Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.

SEC source: 0001127602-17-005160 · form4.xml · derivative · entry 1

Jeffcoat C. Britt · CIK 0001643306 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,752

Underlying: Common Stock, $.0001 Par Value · 24,752 shares

Expires 2027-02-09

F1 · derivative.exercise_date: Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.

SEC source: 0001127602-17-005151 · form4.xml · derivative · entry 1

Kepler Jody · CIK 0001693167 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,505

Underlying: Common Stock, $.0001 Par Value · 49,505 shares

Expires 2027-02-09

F1 · derivative.exercise_date: Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.

SEC source: 0001127602-17-005021 · form4.xml · derivative · entry 1

GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,185

Underlying: Common Stock, $.0001 Par Value · 136,185 shares

Expires 2019-12-31

F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels.

F2 · derivative.exercise_price: Depending on Company's stock price, as measured by 20-day average stock price ending December 31, 2019, payout may be 0, 50%, 100% or 200% of reported amount.

F2 · shares: Depending on Company's stock price, as measured by 20-day average stock price ending December 31, 2019, payout may be 0, 50%, 100% or 200% of reported amount.

F1 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels.

SEC source: 0001127602-17-005030 · form4.xml · derivative · entry 2

Evans Dave · CIK 0001545303 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,669

Underlying: Common Stock, $.0001 Par Value · 7,669 shares

Expires 2019-12-31

F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels.

F3 · shares: Depending on Company's stock price, as measured by 20-day average stock price ending December 31, 2019, payout may be 0, 50%, 100% or 150% of reported amount.

F2 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels.

SEC source: 0001127602-17-005030 · form4.xml · derivative · entry 1

Evans Dave · CIK 0001545303 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,752

Underlying: Common Stock, $.0001 Par Value · 24,752 shares

Expires 2027-02-08

F1 · shares: Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.

SEC source: 0001127602-17-005014 · form4.xml · derivative · entry 2

Schott Alex · CIK 0001685340 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,337

Underlying: Common Stock, $.0001 Par Value · 15,337 shares

Expires 2019-12-31

F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels.

F3 · derivative.exercise_price: Depending on Company stock price at the end of the performance period, payout may be 0, 50%, 100% or 150% of reported amount.

F3 · shares: Depending on Company stock price at the end of the performance period, payout may be 0, 50%, 100% or 150% of reported amount.

F2 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels.

SEC source: 0001127602-17-005014 · form4.xml · derivative · entry 1

Schott Alex · CIK 0001685340 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,505

Underlying: Common Stock, $.0001 Par Value · 49,505 shares

Expires 2027-02-08

F1 · derivative.exercise_date: Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.

SEC source: 0001127602-17-005011 · form4.xml · derivative · entry 2

Kreger Jeffrey M · CIK 0001383865 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,337

Underlying: Common Stock, $.0001 Par Value · 15,337 shares

Expires 2019-12-31

F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels.

F3 · derivative.exercise_price: Depending on Company's stock price, as measured by 20-day average stock price ending December 31, 2019, payout may be 0, 50%, 100% or 150% of reported amount.

F3 · shares: Depending on Company's stock price, as measured by 20-day average stock price ending December 31, 2019, payout may be 0, 50%, 100% or 150% of reported amount.

F2 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels.

SEC source: 0001127602-17-005011 · form4.xml · derivative · entry 1

Kreger Jeffrey M · CIK 0001383865 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,505

Underlying: Common Stock, $.0001 Par Value · 49,505 shares

Expires 2027-02-08

F1 · derivative.exercise_date: Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.

SEC source: 0001127602-16-069118 · form4.xml · derivative · entry 2

GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 442,810

Underlying: Common Stock, $.0001 Par Value · 442,810 shares

Expires 2023-12-01

F3 · derivative.exercise_date: Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.

SEC source: 0001127602-16-069118 · form4.xml · derivative · entry 1

GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 377,358

Underlying: Common Stock, $.0001 Par Value · 377,358 shares

Expires 2020-12-31

F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units vest on December 31, 2020. Vested shares will be delivered to the reporting person on or before March 15, 2021.

F2 · derivative.expiration_date: The Restricted Stock Units vest on December 31, 2020. Vested shares will be delivered to the reporting person on or before March 15, 2021.

SEC source: 0001127602-16-066852 · form4.xml · nonDerivative · entry 1

Kreger Jeffrey M · CIK 0001383865 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,628

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide BioScrip, Inc., any security holder of BioScrip, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001127602-16-066777 · form4.xml · nonDerivative · entry 1

GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,000

F1 · shares: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide BioScrip, Inc., any security holder of BioScrip, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001127602-16-066774 · form4.xml · nonDerivative · entry 1

Pate R Carter · CIK 0001641406 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,000

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide BioScrip, Inc., any security holder of BioScrip, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.